RAMM Pharma Corp. Provides Update on Canapar

 RAMM Pharma Corp. Provides Update on Canapar

Not for Dissemination in the US or through US Newswire Services TORONTO, Jan. 21, 2025 (GLOBE NEWSWIRE) — RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: RAMM), is exploring strategic options for the potential sale o…

Author of the article:
Article content
Not for Dissemination in the US or through US Newswire Services
TORONTO, Jan. 21, 2025 (GLOBE NEWSWIRE) RAMM Pharma Corp. (including its wholly owned subsidi…